122-0551
Small moleculeexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
5
Phase 3
3
Phase 4
0
Earliest trial started Mar 1, 2012 (NCT01698333)
Timeline
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- 122-0551
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02742441 | Phase 3 | Jun 1, 2016 | Therapeutics, Inc. |
| NCT02367911 | Phase 3 | Jan 1, 2015 | Therapeutics, Inc. |
| NCT02368210 | Phase 3 | Jan 1, 2015 | Therapeutics, Inc. |
| NCT01700985 | Phase 2 | May 1, 2012 | Therapeutics, Inc. |
| NCT01698333 | Phase 2 | Mar 1, 2012 | Therapeutics, Inc. |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Therapeutics, Inc. | For profit | 5 | 5 | 2 | 2012 |
1 organizations
Page 1 / 1